Acetaminophen (Paracetamol) Overdose — ED Management

Key Points

• The Rumack-Matthew nomogram applies only to a single acute ingestion with a reliable time and a concentration obtained at least 4 hours after ingestion.
• Do not interpret a pre-4-hour acetaminophen concentration as proof that treatment is unnecessary.
• If a potentially toxic ingestion occurred and the 8-hour treatment window will be missed while awaiting results, start NAC empirically.
• Repeated supratherapeutic ingestion and unknown-time exposure require a different pathway using concentration and liver tests.
• NAC remains beneficial after 8 hours and after hepatic injury has started.
• Extended-release products and opioid or anticholinergic coingestion may require repeat concentrations because absorption can be delayed.
• Continue NAC beyond a fixed infusion duration when acetaminophen remains detectable or hepatic injury has not improved.
• Severe acidosis, encephalopathy, rising INR, hypoglycemia, or kidney injury requires toxicology and transplant-center involvement.

Algorithm

1. Determine whether the exposure is single acute, repeated, extended-release/delayed absorption, or unknown time.
2. For a reliable single acute ingestion, obtain a 4-hour or later acetaminophen level and plot on the nomogram.
3. Start NAC immediately if the level is at or above the treatment line or if a toxic exposure cannot be clarified before 8 hours.
4. For unknown-time or repeated ingestion, obtain acetaminophen concentration, AST/ALT, INR, creatinine, glucose, and acid-base studies and treat according to consensus criteria.
5. Repeat acetaminophen levels when delayed absorption is plausible.
6. Trend AST/ALT, INR, acetaminophen, creatinine, glucose, and clinical status during NAC.
7. Continue NAC until laboratory and clinical stopping criteria are met rather than stopping at an arbitrary clock time.
8. Transfer severe acute liver failure early to a transplant center and discuss extracorporeal therapy for extreme high-risk poisoning.

Clinical Synopsis & Reasoning

Early acetaminophen toxicity may be asymptomatic or cause nausea, vomiting, and malaise, so a benign examination does not exclude a dangerous exposure. Obtain exact formulation, dose, time ingestion began, whether ingestion was staggered, coingestants, weight, alcohol use, nutritional status, and pre-existing liver disease. For a reliable single acute ingestion, obtain a serum acetaminophen concentration at 4 hours after ingestion or immediately if the patient presents later, then plot it on the treatment nomogram. Concentrations drawn before 4 hours cannot establish safety. If the time is unreliable, treat the history as unknown and use acetaminophen concentration plus AST/ALT and clinical context. Extended-release preparations and coingested opioids or anticholinergics can delay absorption and may require repeat concentrations. Repeated supratherapeutic ingestion is not evaluated with the nomogram; decisions use dose history, detectable concentration, and aminotransferases. Severe toxicity progresses to marked transaminase elevation, coagulopathy, lactic acidosis, hypoglycemia, encephalopathy, kidney injury, and acute liver failure. Contact a poison center or medical toxicologist for high-risk, delayed, repeated, or clinically severe cases.

Treatment Strategy & Disposition

Start N-acetylcysteine when the 4-hour or later concentration is at or above the treatment line, when the ingestion is potentially toxic and the concentration will not be available by 8 hours, when time is unknown with detectable acetaminophen or elevated AST/ALT, or when repeated ingestion meets treatment criteria. Standard IV and oral NAC regimens are effective; institutions may use a 21-hour three-bag, two-bag, or other validated IV protocol. Do not stop NAC simply because the planned infusion time has elapsed. Continue until acetaminophen is undetectable, transaminases are improving or normal, INR is acceptable or improving, and the patient is clinically well according to consensus stopping criteria. Activated charcoal can reduce absorption when given early, and later use can be considered for large extended-release or delayed-gastric-emptying exposures with toxicology guidance. In high-risk ingestions with severe acidosis or extremely high concentrations, consultation should address fomepizole and hemodialysis, though fomepizole is not routine standard therapy. Acute liver failure requires early transfer to a transplant-capable center and serial prognostic assessment.

Epidemiology / Risk Factors

• Acetaminophen is one of the most common medication overdoses in North America and a leading cause of acute liver failure.
• Both intentional single ingestions and unintentional repeated supratherapeutic dosing cause serious toxicity.
• Risk rises when multiple combination products unknowingly contribute acetaminophen.
• Delayed presentation is a major predictor of liver injury because NAC is most effective when started within 8 hours.
• Most patients treated early with NAC never develop clinically important hepatotoxicity.

Investigations

N-acetylcysteine Regimens (Abbrev.)

Pharmacology

Prognosis / Complications

• Prognosis is excellent when NAC begins within 8 hours of a potentially toxic acute ingestion.
• Patients who present after hepatic injury develops can still recover with continued NAC and intensive supportive care.
• Acute liver failure with severe acidosis, encephalopathy, rising INR, lactate elevation, and kidney injury has a worse prognosis and may require transplantation.
• Renal injury can occur with or without severe hepatic failure.
• Psychiatric and safety assessment is essential after intentional overdose because prevention of recurrence is part of outcome.

Patient Education / Counseling

• Teach patients to read labels for acetaminophen or APAP in combination cold, pain, and opioid products.
• Do not exceed the recommended daily dose, especially with chronic liver disease, heavy alcohol use, or prolonged fasting without clinician guidance.
• After an overdose, complete the NAC course until the medical team confirms laboratory stopping criteria are met.
• Intentional ingestion should lead to mental-health assessment and a safe disposition plan after medical stabilization.
• Contact poison services or seek emergency care promptly after a potentially toxic dose because treatment is most effective before symptoms appear.

Notes

Acetaminophen poisoning is easy to treat well when the exposure category is identified correctly. A reliable single acute ingestion belongs on the nomogram; an unknown-time or repeated ingestion does not. NAC should begin early when there is uncertainty and continue until the patient, acetaminophen concentration, aminotransferases, and synthetic function meet stopping criteria. The clock is not the endpoint. Severe acidosis or liver failure should trigger toxicology and transplant-center involvement early, before irreversible deterioration removes treatment options.

References

1. 2023 US and Canada Consensus Statement on Management of Acetaminophen Poisoning — Link